COMPANY
Clinical Phase 3
Profile checked Oct 10, 2026
Keywords: Psoriasis SFA002
Timeline
- Trial start Phase 2/Phase 3: Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients source ↗
- Trial start Phase 1: Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT06863493 | Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients | Phase 2/Phase 3 | Not yet recruiting | Jun 1, 2025 | Jun 1, 2026 (estimated) |
| NCT05642182 | Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques | Phase 1 | Recruiting | Mar 31, 2022 | Jul 30, 2025 (estimated) |
